B2DG Events - This Year

Topic Speakersort icon Title Company Date Location
Immuno-oncology 2017 - The crux of the matter, the thrill of the chase Alex Franzusoff, PhD Senior Vice President, Research and Product Development PACT Pharma, Inc 02/14/2017 - 6:00pm Wilson
Novel in-office solution for the treatment of infections of the middle ear in children Amir Abolfathi President & CEO Tusker Medical 06/13/2017 - 6:00pm Wilson
The Digital Health Revolution: Challenges and Opportunities Anne Merritt, MD Clinical Instructor in Emergency Medicine Stanford University 04/18/2017 - 8:30am Sunnyvale
Drug Safety and Pharmacovigilance, the Past, Present and Future Anupam Agarwal, MD, MPH Head of Clinical Safety and Pharmacovigilance Zogenix, Inc. 08/08/2017 - 6:00pm Wilson
Laying a unique scientific approach in precision care for preventing many diseases Atta Pilram Founder & President Care Anytime 11/07/2017 - 8:30am Sunnyvale
From Condoms to Brain Implants: Protecting Patient Safety Across the Device Spectrum Through Biological Assessment Audrey Turley, RM(NRCM), CBA(ASQ) Biocompatibility Expert Nelson Laboratories 12/05/2017 - 8:30am Sunnyvale
Morning Meeting Cancelled - However you are invited to the SF Bay Area Biomedical Industry Happy Hour B2DG & BMES Networking Evening Event in place of the morning meeting N/A N/A 03/07/2017 - 5:00pm Campo di
Opportunities and Challenges for the Health Ecosystem in Emerging Countries Bert Wank, Founder & CEO infiniRel Corporation 10/31/2017 - 8:30am Sunnyvale
Commercialization of Innovations: The Larta story Carlos Gutierrez Chief Strategy Officer Larta Institute 01/10/2017 - 6:00pm Wilson
Meeting is cancelled. Next event is February 28th. Check out the details for the Ramki Pitchuiyer event next week , 02/21/2017 - 8:30am Meeting
Specifics of Pharmaceutical development for global clinical trials Chitra Sharma Founder gCompliance, Inc. 08/29/2017 - 8:30am Sunnyvale
Brink of Catastrophe: Catching Addiction Early David Deacon CEO DxRx Inc. 03/14/2017 - 6:00pm Wilson
A Clinical Trial Roadmap: Who, What, When, and How – Practices, Perspectives and Personal Insights David Larwod CEO Valley Fever Solutions 04/25/2017 - 8:30am Sunnyvale
Why Japan should be top of an OUS growth strategy David Smith Co-Founder and Managing Director Asia MedMarket Access/MedMarket Access LLC 06/06/2017 - 8:30am Sunnyvale
The Journey to Mars: The Next Giant Leap for All Mankind Elizabeth Keller Science Manager, Space Biology Project NASA 09/05/2017 - 8:30am Sunnyvale
Vacation for Thanksgiving- No meeting today- Next Meeting is Nov. 28 Family and Friends . 11/21/2017 - 8:00am With
Supply Chains for New Product Introductions Farzin Shadpour Head of Global Supply Chain & Procurement - 01/17/2017 - 8:30am Sunnyvale
Current Trends in Animal Models for Preclinical Evaluations Félix Vega, VMD Principal Consultant Preclinical Consultation 05/02/2017 - 8:30am Sunnyvale
Japan’s Rapidly Aging Society: How to Innovate for This Fumiaki Ikeno, M.D. Program Director (U.S.) Japan Biodesign, Stanford Biodesign Medical Director/Research Associate, Experimental Interventional Laboratory, Division of Cardiology Stanford University 08/15/2017 - 8:30am Sunnyvale
YawaMed's novel approach to treat Deep Vein Thrombosis and Pulmonary Emboli Gerardo Noriega Managing Director GVMED 08/01/2017 - 8:30am Sunnyvale
BioNews and Open Forum Discussions Harry Wachob President & Founder of B2DG Bio2Device Group 03/28/2017 - 8:30am Sunnyvale
Q4 numbers, views from JP Morgan and an open discussion of what the Trump Administration's Impact may be on Healthcare Harry Wachob and Attendees B2DG 01/24/2017 - 8:30am Sunnyvale
Looking in the Rearview Mirror – Can We Say Anything About SFBA Life Science Performance in 2017 Harry Wachob, PhD President The Bio2Device Group 01/03/2017 - 8:30am Sunnyvale
Sprout Medical, Making an Impact in Critical Care Jerry Gibson Chairman & CEO Sprout Medical 11/14/2017 - 6:00pm Wilson
35 Engineering- PCB and Digital Health John "JB" Foreman Engineer-Consultant Thirty Five Engineering 06/20/2017 - 8:30am Sunnyvale
Why Can’t We Just Produce New Brain Neurons and Reverse Neurodegenerative Disease? Judith Kelleher-Andersson Founder, President and CEO Neuronascent, Inc. 05/16/2017 - 8:30am Sunnyvale

Payment Options Dec 12th Evening Event

Attention B2DG members: You must login to your account first to see the members' early-bird admission rate.
If you are not a B2DG member or if you had missed the early-bird deadline, the registration fee is $20. Please follow these instructions to register.

We use PAYPAL to process your online payment. Print and bring a copy of your online receipt with you. If space permits, walk-ins are welcomed; please be prepared to pay $25 at the door (cash or check). There is no refund, exchange, or transfer. Thank you for your cooperation.
To register now, please select your meal preference from the pull-down menu below and enter the attendee's information. Then click on the "Pay Now" button to reach the PayPal payment page. Each attendee must be registered separately.
Make sure you enter the attendee's meal choice, name, and email address.


Meal Choice
Name of Attendee
Email Address